Skip to main content

Peer-Reviewed Study Demonstrates Strong Agreement Between Techcyte’s AI-Assisted Digital Parasitology Workflow and Light Microscopy

December 2025

Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the publication of a peer-reviewed study in Diagnostics (MDPI) evaluating an AI-assisted digital parasitology workflow using Techcyte’s Human Fecal Wet Mount (HFW) algorithm in a routine clinical laboratory setting.

The prospective study, conducted by the Institute for Infectious Diseases at the University of Bern, assessed 208 consecutive diagnostic stool samples over a three-month period, comparing the digital workflow to traditional brightfield microscopy. Results demonstrated excellent agreement, with approximately 98% overall concordance and a Cohen’s kappa of 0.915, indicating strong alignment between AI-assisted digital review and conventional microscopy.

In addition to prospective testing, the authors evaluated a reference panel of archived samples and conducted precision studies involving repeated scans and testing across multiple days. These analyses demonstrated consistent detection and reproducibility, supporting the stability of the workflow under routine laboratory conditions.

“Our goal was to evaluate how an AI-assisted digital parasitology workflow performs under everyday laboratory conditions,” said Dr. Alexander Oberli, lead author of the study. “We observed excellent agreement with light microscopy and consistent performance across repeated testing. The ability to pre-classify objects of interest helped streamline review while maintaining appropriate expert oversight.”

The study also documented cases in which the AI-assisted workflow flagged low-burden parasitic findings that were initially missed during manual microscopy review and subsequently confirmed upon re-examination. These observations support the author’s positioning of the workflow as a screening and efficiency tool that supports laboratory professionals by prioritizing areas of interest for their expert analysis.

“This publication reflects the kind of clinically grounded evidence laboratories look for when evaluating digital pathology solutions,” said Brian Cahoon, Director of Clinical Pathology at Techcyte. “It demonstrates how AI can be responsibly integrated into existing workflows to improve consistency and efficiency while keeping diagnostic decision-making firmly in the hands of trained professionals.”

These findings highlight the potential of AI-assisted digital parasitology to support laboratories facing increasing workload, staffing pressures, and variability inherent to manual microscopy. By demonstrating strong agreement with established diagnostic methods and consistent performance under routine conditions, the study reinforces the role of Techcyte’s platform as a practical, clinically aligned solution for modernizing microscopy-based workflows. As laboratories continue to adopt digital pathology, peer-reviewed evidence such as this illustrates how AI can be responsibly deployed to enhance efficiency, consistency, and confidence in everyday diagnostic practice.